Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Gaelle Bruneteau

Has grant

Research axis: Systemic and muscular factors involved in motor function in ALS; pathogenesis of diaphragmatic impairment in ALS; presymptomatic biomarkers

Université Paris Cité

France

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in France Professors in Neuropsychology Neuropsychology professors in France

Recent Grants

Grant: Close

ALS-GUT-POP : Polluants organiques persistants dans le sang : associations avec la dysbiose du microbiote intestinal et la progression de la SLA dans une sous-cohorte de l’étude ALS-GUT

Open Date: 2026-01-01

Close Date:

Grant: Close

MODALS: Modulateurs moléculaires de la contractilité diaphragmatique dans la SLA

Open Date: 2026-01-01

Close Date:

Grant: Close

ALS-GUT: Metagenomic Characterisation of the Intestinal Microbiota in ALS and Clinical Correlation

Open Date: 2024-01-01

Close Date:

Grant: Close

SON-ALS “Therapeutic approach of repeated transient blood-brain barrier opening in amyotrophic lateral sclerosis. A one-arm, single-center, proof-of-concept study

Open Date: 2023-01-01

Close Date:

Grant: Close

Therapeutic approach of repeated transient blood-brain barrier opening in amyotrophic lateral sclerosis (with Pr Alexandre Carpentier)

Open Date: 2023-01-01

Close Date:

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (19)

Esther Hobson

Senior clinical lecturer

University of Sheffield

UNITED KINGDOM

Gaelle Bruneteau

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (20)

Drivers of Rising Prevalence in Major Motor Neurodegenerative Diseases

Combining SMN2 splicing modifiers with HDAC6 inhibition improves spinal muscular atrophy outcomes

Familial, neuropathological and cellular analysis identify ARPP21 as a major amyotrophic lateral sclerosis associated gene in French cohorts.

Tofersen Treatment in SOD1-ALS: Real-World Evidence from a Retrospective Multicenter Study in France (FORSLA Study).

Integrative analysis of drug-gene signatures in human pluripotent stem cells reveals prazosin as a novel SQSTM1 regulator for ALS therapeutics.

Primary Lateral Sclerosis French National Diagnostic and Care Protocol.

Association between dyspnea and cognitive task performance in amyotrophic lateral sclerosis: An exploratory study.

Serious neurologic adverse events in Tofersen clinical trials for amyotrophic lateral sclerosis

Long-term tofersen in SOD1 amyotrophic lateral sclerosis

Prevalence of SOD1 and C9orf72 Variants Among French ALS Population: The GENIALS Study.

Time Trends in Incidence of Motor Neuron Diseases in France: A Comprehensive 14-Year Nationwide Study (2010-2023).

Dysregulation of muscle cholesterol transport in amyotrophic lateral sclerosis.

Effect of ultrasound-mediated blood-spinal cord barrier opening on survival and motor function in females in an amyotrophic lateral sclerosis mouse model.

Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognition.

Development and Evaluation of a Simulation-Based Algorithm to Optimize the Planning of Interim Analyses for Clinical Trials in ALS

Comparison of spinal magnetic resonance imaging and classical clinical factors in predicting motor capacity in amyotrophic lateral sclerosis

C9ORF72 knockdown triggers FTD-like symptoms and cell pathology in mice

Quantitative brainstem and spinal MRI in amyotrophic lateral sclerosis: implications for predicting noninvasive ventilation needs

NADPH oxidase 4 inhibition is a complementary therapeutic strategy for spinal muscular atrophy.

Cannabis for the treatment of amyotrophic lateral sclerosis: What is the patients’ view?

Collaborators (19)

Esther Hobson

Morwena Latouche

Christopher McDermott

Teresinha Evangelista

Fredrik Piehl

DOURAIED BEN SALEM

Stéphanie Millecamps

Philip Van Damme

Caroline Ingre

Pascal Reynier

Pascal Leblanc

Karin Modig

Stéphanie Bauché

Sophie Nicole

Dang Wei

Veronique Marchand-Pauvert

Sébastien Dussaud

Frederic Charbonnier

Dominique Deplanque

Make your next move.